F-group (family)
102.1.2.1 HhH-GPD
Ligands and drugs
462
Member domains
152
with ligand contacts (≤ 4 Å)
32.9% of members
122
with DrugDomain annotations
26.4% of members
42
with a DrugBank compound
9.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 102.1.2.1 belongs to X-group 102 HhH/H2TH, which binds 6.9 ligand superclasses per 20 proteins, narrower than 61% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03345 | BME | Mercaptoethanol | 5 |
| DB00437 | 7HP | 7-HYDROXY-PYRAZOLO[4,3-D]PYRIMIDINE | 2 |
| DB01952 | EA1 | 1,N6-Ethenoadenine | 2 |
| DB03730 | 39A | 3,9-Dimethyladenine | 2 |
| DB03975 | MBO | Mercuribenzoic Acid | 2 |
| DB02379 | BGC | Beta-D-Glucose | 1 |
| DB02502 | 8HG | 8-hydroxy-2'-deoxyguanosine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NImetal | NICKEL (II) ION | 74 |
| CAmetal | CALCIUM ION | 16 |
| NAmetal | SODIUM ION | 15 |
| MGmetal | MAGNESIUM ION | 9 |
| CL | CHLORIDE ION | 8 |
| SEQ | ~{N}-cyclohexyl-2-cyclopropyl-quinazolin-4-amine | 8 |
| SF4 | IRON/SULFUR CLUSTER | 6 |
| BME | BETA-MERCAPTOETHANOL | 5 |
| K8Q | 4-(4-bromanyl-2-oxidanylidene-3~{H}-benzimidazol-1-yl)-~{N}-(4-iodophenyl)piperidine-1-carboxamide | 5 |
| A1IBL | 2-azanyl-8-propyl-3,7-dihydropurine-6-thione | 3 |
| A1ID3 | 3-(2-azanylethyl)-2-pyridin-3-yl-1~{H}-indol-5-ol | 3 |
| A1IEJ | 2-(2-pyridin-3-yl-1~{H}-indol-3-yl)ethanamine | 3 |
| AUS | (2~{R})-~{N}-(4,5,6,7-tetrahydro-1,2-benzoxazol-3-yl)spiro[2.3]hexane-2-carboxamide | 3 |
| ELB | 4-(4-azanyl-2-oxidanylidene-3~{H}-benzimidazol-1-yl)-~{N}-(4-iodophenyl)piperidine-1-carboxamide | 3 |
| ELK | ~{N}-(3-methoxy-4-methyl-phenyl)-4-(4-methoxy-2-oxidanylidene-3~{H}-benzimidazol-1-yl)piperidine-1-carboxamide | 3 |
| IFT | 2-[4-(2,4-dimethyl-1~{H}-imidazol-5-yl)phenyl]-~{N}-(4,5,6,7-tetrahydro-1,2-benzoxazol-3-yl)ethanamide | 3 |
| IGQ | (7~{R})-~{N}-(4,5,6,7-tetrahydro-1,2-benzoxazol-3-yl)bicyclo[4.2.0]octa-1,3,5-triene-7-carboxamide | 3 |
| IKL | 2-[4-(3,5-dimethylpyrazol-1-yl)phenyl]-~{N}-(4,5,6,7-tetrahydro-1,2-benzoxazol-3-yl)ethanamide | 3 |
| IUX | ~{N}-[(1~{S})-1,2,2-trimethylcyclopropyl]pyrrolo[1,2-c]pyrimidine-3-carboxamide | 3 |
| S5Y | 2-(2-ethoxyethoxy)ethanethiol | 3 |